Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population

Indian Journal of Psychiatry

Volumn 56, Issue 1, 2014, Pages 46-53

  Narayan, Sunil K ^a   Verman, Arul ^a   Kattimani, Shivanand ^a   Ananthanarayanan, P H ^a   Adithan, Chandrasekaran ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Depression; plasma homocysteine; schizophrenia

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; HYPERHOMOCYSTEINEMIA; ICD-10; INDIA; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PATIENT REFERRAL; PHENOMENOLOGY; SCHIZOPHRENIA;

EID: 84892708391     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.124746     Document Type: Article

References (53)

1. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-90.
2. Madhav SM. Epidemiological study of prevalence of mental disorders in India. Indian J Commu Med 2001; 26: 192-200.
3. Derkach KV, Shpakov AO, Uspenskaia ZI, Iudin AL. The study of molecular mechanisms of action of natural amino acids and serotonin on adenylyl and guanylyl cyclases of the ciliates. Tsitologiia 2012; 54: 270-7.
4. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22: 215-27.
5. Abbott MH, Folstein SE, Abbey H, Pyeritz RE. Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: Prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet 1987; 26: 959-69.
6. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22: 1752-62.
7. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94: 5923-8.
8. Vinchurkar MS, Sathye SM, Dikshit M. Retinitis pigmentosa genetics: A study in Indian population. Indian J Ophthalmol 1996; 44: 77-82.
9. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60: 618-26.
10. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159: 2099-101.
11. Tolmunen T, Hintikka J, Voutilainen S, Ruusunen A, Alfthan G, Nyyssonen K, et al. Association between depressive symptoms and serum concentrations of homocysteine in men: A population study. Am J Clin Nutr 2004; 80: 1574-8.
12. Chen CS, Tsai JC, Tsang HY, Kuo YT, Lin HF, Chiang IC, et al. Homocysteine levels, MTHFR C677T genotype, and MRI Hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005; 13: 869-75.
13. Reif A, Pfuhlmann B, Lesch KP. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1162-8.
14. Fraguas R Jr, Papakostas GI, Mischoulon D, Bottiglieri T, Alpert J, Fava M. Anger attacks in major depressive disorder and serum levels of homocysteine. Biol Psychiatry 2006; 60: 270-4.
15. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 2008; 192: 268-74.
16. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: A meta-analysis. Mol Psychiatry 2006; 11: 143-9.
17. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 2002; 159: 1790-2.
18. de Haan L, van Amelsvoort T, Linszen DH. Elevated homocysteine levels in schizophrenia. Am J Psychiatry 2004; 161: 1131-2.
19. Applebaum J, Shimon H, Sela BA, Belmaker RH, Levine J. Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 2004; 38: 413-6.
20. Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry 2004; 161: 1705-8.
21. Lee YS, Han DH, Jeon CM, Lyoo IK, Na C, Chae SL, et al. Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients. Neuroreport 2006; 17: 743-6.
22. Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, et al. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry 2006; 60: 265-9.
23. Haidemenos A, Kontis D, Gazi A, Kallai E, Allin M, Lucia B. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1289-96.
24. Akanji AO, Ohaeri JU, Al-Shammri SA, Fatania HR. Associations of blood homocysteine concentrations in Arab schizophrenic patients. Clin Biochem 2007; 40: 1026-31.
25. Petronijevic ND, Radonjic NV, Ivkovic MD, Marinkovic D, Piperski VD, Duricic BM, et al. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1921-6.
26. Feng LG, Song ZW, Xin F, Hu J. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study. Psychiatry Res 2009; 168: 205-8.
27. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US Population. Psychother Psychosom 2003; 72: 80-7.
28. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154: 426-8.
29. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B (12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000; 157: 715-21.
30. Virgos C, Martorell L, Simo JM, Valero J, Figuera L, Joven J, et al. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: Lack of association with schizophrenia. Neuroreport 1999; 10: 2035-8.
31. Muntjewerff JW, van der Put N, Eskes T, Ellenbroek B, Steegers E, Blom H, et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: Low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 2003; 121: 1-9.
32. Vilella E, Virgos C, Murphy M, Martorell L, Valero J, Simo JM, et al. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1169-74.
33. Bar-Sella P, Rakover Y, Ratner D. Vitamin B12 and folate levels in long-term vegans. Isr J Med Sci 1990; 26: 309-12.
34. Dastur DK, Quadros EV, Wadia NH, Desai MM, Bharucha EP. Effect of vegetarianism and smoking on vitamin B12, thiocyanate, and folate levels in the blood of normal subjects. Br Med J 1972; 3: 260-3.
35. Rasool S, Abid S, Iqbal MP, Mehboobali N, Haider G, Jafri W. Relationship between vitamin B12, folate and homocysteine levels and H. pylori infection in patients with functional dyspepsia: A cross-section study. BMC Res Notes 2012; 5: 206.
36. Sartorius N. Classification of mental disorders according to ICD. Encephale 1995; 21 Spec No 5: 9-13.
37. Knesevich JW, Biggs JT, Clayton PJ, Ziegler VE. Validity of the hamilton rating scale for depression. Br J Psychiatry 1977; 131: 49-52.
38. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76.
39. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988; 23: 99-110.
40. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006; 580: 2994-3005.
41. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228-32.
42. Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med 2005; 35: 529-38.
43. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, et al. Clinical relevance of low serum vitamin B12 concentrations in older people: The Banbury B12 study. Age Ageing 2006; 35: 416-22.
44. Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, Flicker L. Homocysteine and depression in later life. Arch Gen Psychiatry 2008; 65: 1286-94.
45. Kim JM, Kim SW, Shin IS, Yang SJ, Park WY, Kim SJ, et al. Folate, vitamin B (12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 2008; 5: 36-40.
46. Adler Nevo G, Meged S, Sela BA, Hanoch-Levi A, Hershko R, Weizman A. Homocysteine levels in adolescent schizophrenia patients. Eur Neuropsychopharmacol 2006; 16: 588-91.
47. Kim TH, Moon SW. Serum homocysteine and folate levels in korean schizophrenic patients. Psychiatry Investig 2011; 8: 134-40.
48. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J. Schizophrenia and impaired homocysteine metabolism: A possible association. Biol Psychiatry 1998; 44: 141-3.
49. Regland B. Schizophrenia and single-carbon metabolism. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1124-32.
50. Bottiglieri T, Hyland K. S-adenosyl methionine levels in psychiatric and neurological disorders: A review. Acta Neurol Scand Suppl 1994; 154: 19-26.
51. Obeid R, McCaddon A, Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007; 45: 1590-606.
52. Remington G, Kapur S, Foussias G, Agid O, Mann S, Borlido C, et al. Tetrabenazine augmentation in treatment-resistant schizophrenia: A 12-week, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2012; 32: 95-9.
53. Hillemacher T, Frieling H, Muschler MA, Bleich S. Homocysteine and epigenetic DNA methylation: A biological model for depression?. Am J Psychiatry 2007; 164: 1610.